|
NL6515701A
(enExample)
|
1964-12-03 |
1966-06-06 |
|
|
|
US3525750A
(en)
|
1966-05-31 |
1970-08-25 |
Geigy Chem Corp |
1,2,3,4,5,6-hexahydro-azepino(4,5-b) indole derivatives
|
|
US3553232A
(en)
|
1967-08-25 |
1971-01-05 |
Upjohn Co |
4-(1,4,5,6-tetrahydroazepine(4,5-b)indole-3(2h)-yl)butyrophenones
|
|
US3637744A
(en)
|
1969-04-04 |
1972-01-25 |
American Home Prod |
Indoleazocines
|
|
US3652588A
(en)
|
1969-10-23 |
1972-03-28 |
Upjohn Co |
6-alkyl-1 2 3 4 5 6-hexahydroazepino(4 5-b)indoles
|
|
DE3070467D1
(en)
|
1979-11-02 |
1985-05-15 |
Sandoz Ag |
Azepinoindoles, process for their production and pharmaceutical compositions containing them
|
|
US4581354A
(en)
|
1984-08-06 |
1986-04-08 |
Sterling Drug Inc. |
3-arylcarbonyl- and 3-cycloalkylcarbonyl-1-aminoalkyl-1H-indoles, compositions and use
|
|
GB8419278D0
(en)
|
1984-07-27 |
1984-08-30 |
Lilly Industries Ltd |
Pharmaceutical compounds
|
|
DE3809155A1
(de)
|
1988-03-18 |
1989-09-28 |
Bayer Ag |
1,3,4,5-tetrahydrobenz-(c,d)-indole
|
|
US5068234A
(en)
|
1990-02-26 |
1991-11-26 |
Sterling Drug Inc. |
3-arylcarbonyl-1-(c-attached-n-heteryl)-1h-indoles
|
|
HUT61548A
(en)
|
1990-08-27 |
1993-01-28 |
Sandoz Ag |
Process for producing indolonaphthyridine derivatives and pharmaceutical compositions comprising such compounds
|
|
FR2674522B1
(fr)
|
1991-03-26 |
1993-07-16 |
Lipha |
Nouveaux derives de l'indole, procedes de preparation et medicaments les contenant.
|
|
DE4238994A1
(de)
|
1992-11-19 |
1994-05-26 |
Basf Ag |
Aniline als Markierungsmittel für Mineralöle
|
|
EP0620222A3
(en)
|
1993-04-14 |
1995-04-12 |
Lilly Co Eli |
Tetrahydro-beta-carbolines.
|
|
US5852046A
(en)
|
1993-08-03 |
1998-12-22 |
Hoechst Aktiengesellschaft |
Benzo-fused heterocyclic compounds having a 5-membered ring processes for their preparation their use as medicaments their use as diagnostic agents and medicaments containing them
|
|
TW270114B
(enExample)
|
1993-10-22 |
1996-02-11 |
Hoffmann La Roche |
|
|
JPH09510216A
(ja)
|
1994-03-11 |
1997-10-14 |
イーライ・リリー・アンド・カンパニー |
５−ｈｔ▲下２ｂ▼受容体に関連する病態を治療するための方法
|
|
GB9408577D0
(en)
|
1994-04-29 |
1994-06-22 |
Fujisawa Pharmaceutical Co |
New compound
|
|
NZ301265A
(en)
*
|
1995-02-02 |
1998-12-23 |
Smithkline Beecham Plc |
Indole derivatives as 5ht receptor antagonists, preparation and pharmaceutical compositions thereof
|
|
US5843682A
(en)
|
1995-11-20 |
1998-12-01 |
Boehringer Mannheim Corporation |
N-1-carboxyalkyl derivatives of LSD
|
|
GB9609641D0
(en)
|
1996-05-09 |
1996-07-10 |
Pfizer Ltd |
Compounds useful in therapy
|
|
AU6417198A
(en)
|
1997-03-13 |
1998-09-29 |
Bioresearch Ireland a division of Eolas - The Irish Science and Technology Agency |
Cytoprotective agents comprising monoamine oxidase inhibitors
|
|
GB9819033D0
(en)
|
1998-09-01 |
1998-10-28 |
Cerebrus Ltd |
Chemical compounds VI
|
|
CA2356638A1
(en)
|
1998-12-23 |
2000-07-06 |
Nps Allelix Corp. |
Indole and indolizidine derivatives for the treatment of migraine
|
|
PE20010052A1
(es)
*
|
1999-04-23 |
2001-01-27 |
Upjohn Co |
Compuestos de azepinindol tetraciclico como agonistas o antagonistas del receptor de 5-ht
|
|
US6407092B1
(en)
|
1999-04-23 |
2002-06-18 |
Pharmacia & Upjohn Company |
Tetracyclic azepinoindole compounds
|
|
US7071186B2
(en)
|
1999-06-15 |
2006-07-04 |
Bristol-Myers Squibb Pharma Co. |
Substituted heterocycle fused gamma-carbolines
|
|
WO2000077001A1
(en)
|
1999-06-15 |
2000-12-21 |
Du Pont Pharmaceuticals Company |
Substituted heterocycle fused gamma-carbolines
|
|
MY122278A
(en)
|
1999-07-19 |
2006-04-29 |
Upjohn Co |
1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position
|
|
EP1263434A1
(en)
|
2000-03-17 |
2002-12-11 |
Alcon, Inc |
Compounds with 5-ht 2 and 5-ht 1a agonist activity for treating glaucoma
|
|
WO2002004456A1
(en)
|
2000-07-06 |
2002-01-17 |
Pharmacia & Upjohn Company |
SUBSTITUTED 2,3,7,8,9,10,11,12-OCTAHYDROAZEPINO[4,5-b]PYRANO[3,2-e]INDOLES
|
|
JP2004509074A
(ja)
|
2000-07-06 |
2004-03-25 |
ファルマシア・アンド・アップジョン・カンパニー |
アゼピノ［４，５−ｂ］ピラノ［３，２−ｅ］インドール
|
|
WO2002012226A1
(en)
|
2000-08-09 |
2002-02-14 |
Astrazeneca Ab |
Quinoline derivatives having vegf inhibiting activity
|
|
IL153805A0
(en)
|
2000-08-09 |
2003-07-31 |
Astrazeneca Ab |
Cinnoline compounds
|
|
US20070243240A9
(en)
|
2000-08-24 |
2007-10-18 |
Fred Windt-Hanke |
Transdermal therapeutic system
|
|
JP2004509894A
(ja)
*
|
2000-09-20 |
2004-04-02 |
ファルマシア・アンド・アップジョン・カンパニー |
置換アゼピノ［４，５−ｂ］インドリン誘導体
|
|
MXPA03005355A
(es)
|
2000-12-20 |
2004-05-27 |
Bristol Myers Squibb Co |
Pirroloquinolinas y piridoquinolinas sustituidas como agonistas y antagonistas de serotonina.
|
|
RU2003121304A
(ru)
|
2000-12-20 |
2005-01-27 |
Бристол-Маерс Сквибб Компани (Us) |
Замещенные пиридоиндолы в качестве агонистов и антагонистов серотонина
|
|
ES2193839B1
(es)
|
2001-06-22 |
2005-02-16 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de 6-fenildihidropirrolpirimidindiona.
|
|
AR038118A1
(es)
|
2002-01-14 |
2004-12-29 |
Upjohn Co |
Compuestos derivados de la bencinamida del acido 7-oxo-4,7-dihidrotien[2,3-b[piridin-6-carboxilico 3-sustituido que son utiles como antivirales
|
|
TWI329111B
(en)
|
2002-05-24 |
2010-08-21 |
X Ceptor Therapeutics Inc |
Azepinoindole and pyridoindole derivatives as pharmaceutical agents
|
|
TW200400177A
(en)
|
2002-06-04 |
2004-01-01 |
Wyeth Corp |
1-(Aminoalkyl)-3-sulfonylindole and-indazole derivatives as 5-hydroxytryptamine-6 ligands
|
|
UA78999C2
(en)
|
2002-06-04 |
2007-05-10 |
Wyeth Corp |
1-(aminoalkyl)-3-sulfonylazaindoles as ligands of 5-hydroxytryptamine-6
|
|
WO2004005389A1
(ja)
|
2002-07-09 |
2004-01-15 |
Orient Chemical Industries, Ltd. |
核効果抑制剤、結晶性樹脂組成物及び結晶性樹脂組成物の結晶化制御法
|
|
ATE407117T1
(de)
|
2003-01-16 |
2008-09-15 |
Acadia Pharm Inc |
Selektive serotonin 2a/2c inverse rezeptoragonisten als therapeutika für neurodegenerative erkrankungen
|
|
US20050250767A1
(en)
|
2003-01-23 |
2005-11-10 |
Weiner David M |
Use of N-desmethylclozapine to treat human neuropsychiatric disease
|
|
US20070197603A1
(en)
|
2003-07-04 |
2007-08-23 |
Alessandra Consonni |
Substituted indole ligands for the orl-1 receptor
|
|
AU2004260758B2
(en)
|
2003-08-01 |
2007-06-07 |
Nippon Soda Co., Ltd. |
Phenylazole compounds, production process, and antioxidants
|
|
US8519158B2
(en)
|
2004-03-12 |
2013-08-27 |
Ligand Pharmaceuticals Incorporated |
Androgen receptor modulator compounds and methods
|
|
EP1632491A1
(en)
*
|
2004-08-30 |
2006-03-08 |
Laboratorios Del Dr. Esteve, S.A. |
Substituted indole compounds and their use as 5-HT6 receptor modulators
|
|
GB0500492D0
(en)
|
2005-01-11 |
2005-02-16 |
Cyclacel Ltd |
Compound
|
|
JP2008530136A
(ja)
|
2005-02-14 |
2008-08-07 |
ミイカナ セラピューティクス インコーポレイテッド |
ヒストンデアセチラーゼの阻害剤として有用な縮合複素環化合物
|
|
US20070213359A1
(en)
|
2005-12-30 |
2007-09-13 |
Acadia Pharmaceuticals Inc. |
Bicyclic-nitrogen compounds as modulators of ghrelin receptor and uses thereof
|
|
ZA200809659B
(en)
|
2006-04-13 |
2010-03-31 |
Neuraxon Inc |
1,5 and 3,6-substituted indole compounds having NOS inhibitory activity
|
|
MX394214B
(es)
|
2007-03-12 |
2025-03-24 |
Intra Cellular Therapies Inc |
Sintesis de gamma-carbolinas fusionadas con heterociclo substituido.
|
|
WO2008117935A1
(en)
|
2007-03-28 |
2008-10-02 |
Industry-Academic Cooperation Foundation, Yonsei University |
Nk cell activating molecules, nk cells and pharmaceutical compositons comprising the same
|
|
EP3524248A1
(en)
|
2007-06-21 |
2019-08-14 |
VeroScience LLC |
Method of treating metabolic disorders and depression with dopamine receptor agonists
|
|
JP2010534665A
(ja)
|
2007-07-25 |
2010-11-11 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
グルココルチコイドミメチックス、それらの製造方法、医薬組成物、及びこれらの使用
|
|
US8318813B2
(en)
|
2007-09-13 |
2012-11-27 |
Lcs Group, Llc |
Method of treating binge eating disorder
|
|
AR068509A1
(es)
|
2007-09-19 |
2009-11-18 |
Jerini Ag |
Antagosnistas del receptor de bradiquinina b1
|
|
RU2007139634A
(ru)
|
2007-10-25 |
2009-04-27 |
Сергей Олегович Бачурин (RU) |
Новые тиазол-, триазол- или оксадиазол-содержащие тетрациклические соединения
|
|
WO2009103022A1
(en)
|
2008-02-13 |
2009-08-20 |
Itherx Pharmaceuticals, Inc. |
Derivatives of substituted fused ring cycloindoles and methods of their use
|
|
TWI443098B
(zh)
|
2008-03-24 |
2014-07-01 |
Medivation Technologies Inc |
吡啶并〔３，４－ｂ〕吲哚及使用方法
|
|
CN102316732B
(zh)
|
2008-10-31 |
2015-04-01 |
梅迪维新技术公司 |
氮杂*并[4,5-b]吲哚以及使用方法
|
|
CA2748813C
(en)
|
2009-01-09 |
2018-07-10 |
Board Of Regents Of The University Of Texas System |
Pro-neurogenic compounds
|
|
US8362277B2
(en)
|
2009-01-09 |
2013-01-29 |
Board Of Regents Of The University Of Texas System |
Pro-neurogenic compounds
|
|
US9962368B2
(en)
|
2009-01-09 |
2018-05-08 |
Board Of Regents Of The University Of Texas System |
Pro-neurogenic compounds
|
|
US9162980B2
(en)
|
2009-01-09 |
2015-10-20 |
Board Of Regents Of The University Of Texas System |
Anti-depression compounds
|
|
WO2011003005A1
(en)
|
2009-07-01 |
2011-01-06 |
Albany Molecular Research, Inc. |
Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine mch-1 antagonists, methods of making, and use thereof
|
|
US8367655B2
(en)
|
2009-07-03 |
2013-02-05 |
Daya Drug Discoveries, Inc. |
Pyridoindolobenzox—and thiazepine derivatives and uses thereof
|
|
WO2011079102A1
(en)
|
2009-12-23 |
2011-06-30 |
Sanofi |
Indolyl-piperidinyl benzylamines as beta-tryptase inhibitors
|
|
CN102906752B
(zh)
|
2010-01-18 |
2017-09-01 |
艾欧敏达有限公司 |
用于神经生理学数据的加权分析的方法和系统
|
|
WO2012144972A2
(en)
|
2010-01-19 |
2012-10-26 |
The General Hospital Corporation |
Methods to inhibit neurodegeneration
|
|
US9040519B2
(en)
|
2010-02-18 |
2015-05-26 |
Medivation Technologies, Inc. |
Fused tetracyclic pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use
|
|
US9034865B2
(en)
|
2010-02-18 |
2015-05-19 |
Medivation Technologies, Inc. |
Pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use
|
|
US9187471B2
(en)
|
2010-02-19 |
2015-11-17 |
Medivation Technologies, Inc. |
Pyrido [4,3-b] indole and pyrido [3,4-b] indole derivatives and methods of use
|
|
US9393198B2
(en)
|
2010-03-22 |
2016-07-19 |
Signpath Pharma Inc. |
Intravenous curcumin and derivatives for treatment of neurodegenerative and stress disorders
|
|
US8796254B2
(en)
|
2010-03-31 |
2014-08-05 |
Rigel Pharmaceuticals, Inc. |
Methods for using carboxamide, sulfonamide and amine compounds
|
|
ES2734552T3
(es)
|
2010-04-16 |
2019-12-10 |
Ac Immune Sa |
Compuestos novedosos para el tratamiento de enfermedades asociadas a proteínas amiloides o de tipo amiloide
|
|
US20140155384A1
(en)
|
2011-02-18 |
2014-06-05 |
Medivation Technologies, Inc. |
Compounds and methods of treating diabetes
|
|
WO2012112964A2
(en)
|
2011-02-18 |
2012-08-23 |
Medivation Technologies, Inc. |
PYRIDO[4,3-b]INDOLE AND PYRIDO[3,4-b]INDOLE DERIVATIVES AND METHODS OF USE
|
|
CA2829045A1
(en)
|
2011-02-18 |
2012-08-23 |
Medivation Technologies, Inc. |
Compounds and methods for treatment of hypertension
|
|
WO2012112965A1
(en)
|
2011-02-18 |
2012-08-23 |
Medivation Technologies, Inc. |
Compounds and methods of treating diabetes
|
|
GB201111712D0
(en)
|
2011-07-08 |
2011-08-24 |
Gosforth Ct Holdings Pty Ltd |
Pharmaceutical compositions
|
|
US20130178618A1
(en)
|
2012-01-10 |
2013-07-11 |
William Allen Boulanger |
Novel pharmaceutical intermediates and methods for preparing the same
|
|
US10118943B2
(en)
|
2012-05-16 |
2018-11-06 |
Ramot At Tel-Aviv University Ltd. |
Compounds and methods for inhibiting cell death
|
|
CN102977092B
(zh)
|
2012-11-06 |
2016-02-24 |
华东师范大学 |
芳香烷酰基四氢-β-咔啉及其衍生物在治疗恶性肿瘤中的应用
|
|
CN102977091B
(zh)
|
2012-11-06 |
2016-03-09 |
华东师范大学 |
芳香烷酰基四氢-β-咔啉及其衍生物在治疗代谢性疾病中的应用
|
|
EP2981266B1
(en)
|
2013-03-04 |
2018-01-03 |
Daya CNS LLC |
Pentacyclic pyridoindolobenz[b,d]azepine derivatives and uses thereof
|
|
NZ711598A
(en)
|
2013-03-14 |
2016-09-30 |
Dart Neuroscience Cayman Ltd |
Substituted naphthyridine and quinoline compounds as mao inhibitors
|
|
AU2014241430B2
(en)
|
2013-03-14 |
2018-04-26 |
Dart Neuroscience (Cayman) Ltd. |
Substituted pyridine and pyrazine compounds as PDE4 inhibitors
|
|
US9292659B1
(en)
|
2014-10-29 |
2016-03-22 |
Heartflow, Inc. |
Systems and methods for vessel reactivity to guide diagnosis or treatment of cardiovascular disease
|
|
JP2017031088A
(ja)
|
2015-07-31 |
2017-02-09 |
東レ株式会社 |
インドール誘導体及びその医薬用途
|
|
EP3352566A4
(en)
|
2015-09-23 |
2019-07-31 |
Minerva Biotechnologies Corporation |
SCREENING METHOD FOR ACTIVE SUBSTANCES FOR DIFFERENTIATING STEM CELLS
|
|
JP2017100953A
(ja)
|
2015-11-30 |
2017-06-08 |
東レ株式会社 |
テトラヒドロベンゾフロアゼピン誘導体及びその医薬用途
|
|
GB2550110A
(en)
|
2016-04-28 |
2017-11-15 |
Univ Oxford Innovation Ltd |
Treatment of impulsivity-related disorders
|
|
CN109311876B
(zh)
|
2016-06-16 |
2022-05-03 |
豪夫迈·罗氏有限公司 |
杂芳基雌激素受体调节剂及其用途
|
|
US20180021326A1
(en)
|
2016-07-23 |
2018-01-25 |
Paul Edward Stamets |
Compositions and methods for enhancing neuroregeneration and cognition by combining mushroom extracts containing active ingredients psilocin or psilocybin with erinacines or hericenones enhanced with niacin
|
|
AU2017321708B2
(en)
|
2016-08-31 |
2024-01-04 |
Rutgers, The State University Of New Jersey |
Methods and compositions for treating diseases and disorders of the nervous system
|
|
EP3519816A4
(en)
|
2016-09-29 |
2020-05-06 |
The Regents of the University of California |
CONNECTIONS FOR INCREASING NEURONAL PLASTICITY
|
|
CA3105451A1
(en)
|
2017-05-12 |
2018-11-15 |
Indiana University Research And Technology Corporation |
Precision medicine for treating and preventing suicidality
|
|
WO2019099402A1
(en)
|
2017-11-14 |
2019-05-23 |
Rutgers, The State University Of New Jersey |
Therapeutic compounds and methods to treat infection
|
|
US10583123B2
(en)
|
2017-12-15 |
2020-03-10 |
National Tsing Hua University |
Method for the treatment of ATG4-related disorders
|
|
EP3802533A1
(en)
|
2018-06-04 |
2021-04-14 |
AC Immune SA |
Tetrahydrobenzofuro[2,3-c]pyridine and beta-carboline compounds for the treatment, alleviation or prevention of disorders associated with tau aggregates
|
|
DK3927338T3
(da)
|
2019-02-22 |
2025-01-06 |
Gh Res Ireland Limited |
Sammensætninger omfattende 5-methoxy-n,n-dimethyltryptamin (5-meo-dmt) til anvendelse i behandling af mentale lidelser
|
|
KR102946120B1
(ko)
|
2019-02-27 |
2026-03-30 |
더 리젠츠 오브 더 유니버시티 오브 캘리포니아 |
뇌 장애를 치료하기 위한 아제피노-인돌 및 다른 헤테로사이클
|
|
WO2020176597A1
(en)
|
2019-02-27 |
2020-09-03 |
The Regents Of The University Of California |
N-substituted indoles and other heterocycles for treating brain disorders
|
|
WO2020181050A1
(en)
|
2019-03-05 |
2020-09-10 |
Sperovie Biosciences, Inc. |
Compounds, compositions, and methods for the treatment of disease
|
|
US12616706B2
(en)
|
2019-03-07 |
2026-05-05 |
Arbormentis LLC |
Compositions and methods of use comprising substances with neural plasticity actions administered at non-psychedelic/psychotomimetic dosages and formulations
|
|
WO2020186027A1
(en)
|
2019-03-13 |
2020-09-17 |
Daisuke Tomita |
Inhibitors of cgas for treating autoinflammatory diseases and cancer metastasis
|
|
WO2021003467A1
(en)
|
2019-07-04 |
2021-01-07 |
Sw Holdings, Inc. |
Metered dosing compositions and methods of use of psychedelic compounds
|
|
KR20220100851A
(ko)
|
2019-08-20 |
2022-07-18 |
테란 바이오사이언시스 인코포레이티드 |
파킨슨병을 평가하기 위한 뉴로멜라닌 민감성 mri
|
|
US20230295106A1
(en)
|
2019-10-14 |
2023-09-21 |
The Regents Of The University Of California |
Ergoline-like compounds for promoting neural plasticity
|
|
WO2021178691A1
(en)
|
2020-03-05 |
2021-09-10 |
The Trustees Of Columbia University In The City Of New York |
Ibogaine analogs as therapeutics for neurological and psychiatric disorders
|
|
EP4161503A4
(en)
|
2020-06-08 |
2024-07-03 |
Tactogen Inc. |
Advantageous benzofuran compositions for mental disorders or enhancement
|
|
CA3182093A1
(en)
|
2020-06-10 |
2021-12-16 |
Florence Wagner |
Tricyclic psychoplastogens and uses thereof
|
|
WO2022020352A1
(en)
|
2020-07-20 |
2022-01-27 |
The Trustees Of Columbia University In The City Of New York |
Ibogaine analogs as therapeutics for neurological and psychiatric disorders
|
|
EP4208457A1
(en)
|
2020-09-04 |
2023-07-12 |
Gilgamesh Pharmaceuticals, Inc. |
Azetidinyl tryptamines and methods of treating psychiatric disorders
|
|
WO2022067165A1
(en)
|
2020-09-28 |
2022-03-31 |
Yale University |
Selective agonists of 5-ht2a receptor and methods of use
|
|
US20230384333A1
(en)
|
2020-10-13 |
2023-11-30 |
The Regents Of The University Of California |
Gpcr screening method to identify non-hallucinogenic compounds
|
|
IL302831A
(en)
|
2020-11-16 |
2023-07-01 |
Terran Biosciences Inc |
Neuromelanin-sensitive MRI and methods for its use
|
|
WO2022120181A1
(en)
|
2020-12-03 |
2022-06-09 |
Mydecine Innovations Group Inc. |
Novel psilocin analog compositions and methods of synthesizing the same
|
|
US20240051978A1
(en)
|
2020-12-07 |
2024-02-15 |
Mindset Pharma Inc. |
3-cyclic amine-indole derivatives as serotonergic agents for the treatment of cns disorders
|
|
EP4126857A1
(en)
|
2021-01-15 |
2023-02-08 |
Beckley Psytech Limited |
Ergoline analogues
|
|
AU2022217264A1
(en)
|
2021-02-08 |
2023-09-14 |
The Trustees Of Columbia University In The City Of New York |
Oxa-ibogaine inspired analogues for treatment of neurological and psychiatric disorders
|
|
JP2024512796A
(ja)
|
2021-04-01 |
2024-03-19 |
テラン バイオサイエンシーズ インク． |
サイケデリック薬およびセロトニン受容体調節因子に関する方法と組成物
|
|
WO2022221415A2
(en)
|
2021-04-13 |
2022-10-20 |
The Regents Of The University Of California |
Tetracyclic compounds for treating brain disorders
|
|
WO2022235587A1
(en)
|
2021-05-03 |
2022-11-10 |
Terran Biosciences Inc. |
Lipid prodrugs of tryptamine and phenethylamine psychedelics and uses thereof
|
|
WO2022246554A1
(en)
|
2021-05-26 |
2022-12-01 |
Bright Minds Biosciences Inc. |
Heterocyclic compounds and methods of preparation thereof
|
|
WO2023283373A1
(en)
|
2021-07-07 |
2023-01-12 |
Terran Biosciences Inc. |
3,4-methylenedioxymethamphetamine and related psychedlics and uses thereof
|
|
AU2022309017A1
(en)
|
2021-07-07 |
2024-01-25 |
Terran Biosciences Inc. |
N,n-dimethyltryptamine and related psychedlics and uses thereof
|
|
US20240343692A1
(en)
|
2021-08-09 |
2024-10-17 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Selective psychedelic compounds
|
|
WO2023018864A1
(en)
|
2021-08-12 |
2023-02-16 |
Psilosterics, Llc |
Hallucinogenic and non-hallucinogenic serotonin receptor agonists and methods of making and using the same
|
|
EP4387952A1
(en)
|
2021-08-20 |
2024-06-26 |
Terran Biosciences Inc. |
Deuterated analogs and derivatives of 4-bromo-2,5-dimethoxyphenethylamine and uses thereof
|
|
WO2023023298A1
(en)
|
2021-08-20 |
2023-02-23 |
Psilosterics, Llc |
Hallucinogenic and non-hallucinogenic compounds and methods of making and using the same
|
|
KR20240065084A
(ko)
|
2021-08-20 |
2024-05-14 |
테란 바이오사이언시스 인코포레이티드 |
사일로신의 전구약물 및 유도체 및 그의 용도
|
|
US20240317783A1
(en)
|
2021-09-14 |
2024-09-26 |
Terran Biosciences Inc. |
Processes of preparing psilocin and psilocybin
|
|
WO2023059546A1
(en)
|
2021-10-04 |
2023-04-13 |
Psilosterics, Llc |
Serotonin receptor agonists and methods of making and using the same
|
|
US20230250098A1
(en)
|
2021-10-04 |
2023-08-10 |
University Of Health Sciences & Pharmacy In St. Louis |
Kratom opioid derivatives for the treatment of alcohol use disorder
|
|
CA3232050A1
(en)
|
2021-10-26 |
2023-05-04 |
Methvin Isaac |
Ergoline-derived agonists of the 5-ht2a receptor
|
|
EP4423060A2
(en)
|
2021-10-29 |
2024-09-04 |
Terran Biosciences, Inc. |
Psychoplastogenic n-substituted indoles
|
|
EP4423088A2
(en)
|
2021-10-29 |
2024-09-04 |
Terran Biosciences, Inc. |
Azepino-indoles for the treatment of neurological and psychiatric disorders
|
|
EP4426686A4
(en)
|
2021-11-03 |
2025-11-05 |
Univ California |
N,N-DIMETHYLAMPHTAMIN ANALOGUES FOR THE TREATMENT OF CEREBRAL DISORDERS
|
|
AU2022382937A1
(en)
|
2021-11-03 |
2024-05-16 |
Tactogen Inc |
Indolizine compounds for the treatment of mental disorders or mental enhancement
|
|
WO2023081899A1
(en)
|
2021-11-05 |
2023-05-11 |
Terran Biosciences, Inc. |
Isotopically enriched n-methyl-1,3-benzodioxolylbutanamine (mbdb) and stereoisomers thereof
|
|
WO2023081403A1
(en)
|
2021-11-05 |
2023-05-11 |
Terran Biosciences Inc. |
Isotopologes, salts, crystalline forms, stereoisomers, of methylone and ethylone and methods of use thereof
|
|
US20230181521A1
(en)
|
2021-11-05 |
2023-06-15 |
Terran Biosciences, Inc. |
Isotopically enriched analogs of 5,6-methylenedioxy-2-aminoindane (mdai)
|
|
WO2023081892A1
(en)
|
2021-11-05 |
2023-05-11 |
Terran Biosciences, Inc. |
Analogs of n,n,n-trimethyl-4-phosphoryloxytryptamine
|
|
WO2023081897A1
(en)
|
2021-11-05 |
2023-05-11 |
Terran Biosciences, Inc. |
Isotopically enriched 3,4-methylenedioxy-n-ethylamphetamine (mde) and stereoisomers thereof
|
|
WO2023086962A1
(en)
|
2021-11-12 |
2023-05-19 |
Terran Biosciences Inc. |
Psilocybin and o-acetylpsilocin, salts and solid state forms thereof
|
|
US20230150920A1
(en)
|
2021-11-15 |
2023-05-18 |
Terran Biosciences, Inc. |
Salts and solid forms of 4-bromo-2,5-dimethoxyphenethylamine
|
|
WO2023091974A2
(en)
|
2021-11-16 |
2023-05-25 |
Terran Biosciences, Inc. |
Salt and solid forms of (r)-1-(5-methoxy-1 h-indol-1-yl)-n,n-dimethylpropan-2-amine
|
|
WO2023092044A2
(en)
|
2021-11-17 |
2023-05-25 |
Terran Biosciences, Inc. |
Phenethylamine compounds salts, polymorphic forms and methods of use thereof
|
|
WO2023092045A1
(en)
|
2021-11-17 |
2023-05-25 |
Terran Biosciences, Inc. |
Salt and solid forms of tabernanthalog
|
|
JP2024544586A
(ja)
|
2021-11-26 |
2024-12-03 |
ジ ユニバーシティ オブ ウェスタン オーストラリア |
Ｓｅｒｔ、ｄａｔ、および／またはｎｅｔ活性を調節するためのｍｄｍａの類縁体
|
|
WO2023107965A1
(en)
|
2021-12-06 |
2023-06-15 |
Terran Biosciences, Inc. |
Salt and solid forms of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (dom), 2,5-dimethoxy-4-iodoamphetamine (doi), 2,5-dimethoxy-4-bromoamphetamine (dob), and 2,5-dimethoxy-4-chloroamphetamine (doc)
|
|
WO2023107966A1
(en)
|
2021-12-06 |
2023-06-15 |
Terran Biosciences, Inc. |
Salt and solid forms of lysergic acid diethylamide (lsd) and analogs
|
|
WO2023107931A1
(en)
|
2021-12-06 |
2023-06-15 |
Terran Biosciences, Inc. |
Salt and solid forms of indole analogs and methods of use thereof
|
|
WO2023108164A2
(en)
|
2021-12-10 |
2023-06-15 |
GATC Health Corp |
Methods of treating ptsd and neurological disorders
|
|
WO2023108174A1
(en)
|
2021-12-10 |
2023-06-15 |
Terran Biosciences, Inc. |
Analogs of 6-methoxy- n, n-dimethyltryptamine
|
|
WO2023108172A2
(en)
|
2021-12-11 |
2023-06-15 |
Terran Biosciences, Inc. |
Analogs of 4-substituted-2,5-dimethoxyamphetamine
|
|
JP2025502615A
(ja)
|
2021-12-15 |
2025-01-28 |
デリックス セラピューティクス，インク． |
フェノキシおよびベンジルオキシ置換サイコプラストゲンならびにその使用
|
|
WO2023114858A1
(en)
|
2021-12-15 |
2023-06-22 |
Delix Therapeutics, Inc. |
Benzofuran and benzothiophene psychoplastogens and uses thereof
|
|
MX2024007220A
(es)
|
2021-12-15 |
2024-08-27 |
Delix Therapeutics Inc |
Psicoplastogenos de pirrolidina fusionada y sus usos.
|
|
EP4447954A4
(en)
|
2021-12-16 |
2025-12-03 |
Icahn School Med Mount Sinai |
HETEROCYCLIC COMPOUNDS AS POLARIZED 5HT2A AGONISTS
|
|
US20250049748A1
(en)
|
2021-12-16 |
2025-02-13 |
Terran Biosciences Inc. |
Analogs of 4-bromo-2,5-dimethoxyphenethylamine
|
|
EP4448518A4
(en)
|
2021-12-16 |
2025-12-17 |
Terran Biosciences Inc |
ISOTOPICALLY ENRICHED ANALOYS OF 2-BROM-LSD, LSD, ALD-52 AND 1P-LSD
|
|
US20250057822A1
(en)
|
2021-12-17 |
2025-02-20 |
The Regents Of The University Of California |
Psychoplastogens for treating hearing-related disorders
|
|
WO2023122135A1
(en)
|
2021-12-22 |
2023-06-29 |
Kuleon Llc |
Serotonin receptor agonists and methods of making and using the same
|
|
CA3244229A1
(en)
|
2021-12-24 |
2023-06-29 |
Psylo Pty Ltd |
COMPOUNDS
|
|
JP2025501141A
(ja)
|
2021-12-24 |
2025-01-17 |
サイロ プロプリエタリー リミテッド |
化合物
|
|
CA3242479A1
(en)
|
2021-12-27 |
2023-07-06 |
Atai Therapeutics, Inc. |
AMINOTERALINE SEROTONIN RECEPTOR ACTIVATORS
|
|
WO2023129976A1
(en)
|
2021-12-29 |
2023-07-06 |
Terran Biosciences, Inc. |
Salt and solid forms of ketanserin
|
|
US20250066299A1
(en)
|
2022-01-06 |
2025-02-27 |
Terran Biosciences Inc. |
Salts and solid forms of 4-hydroxy-n,n-diisopropyltryptamine hemi-glutarate and hemi-succinate
|
|
WO2023133524A1
(en)
|
2022-01-06 |
2023-07-13 |
Terran Biosciences, Inc. |
A process for synthesizing ketanserin
|
|
WO2023137453A1
(en)
|
2022-01-14 |
2023-07-20 |
Terran Biosciences Inc. |
Prodrugs of 3,4-methylenedioxy-n-methcathinone and uses thereof
|
|
WO2023137446A1
(en)
|
2022-01-14 |
2023-07-20 |
Terran Biosciences Inc. |
Prodrugs of 3,4-methylenedioxy- n-ethyl-amphetamine (mdea) and uses thereof
|
|
US20250136548A1
(en)
|
2022-01-20 |
2025-05-01 |
Terran Biosciences Inc. |
Functionalized alkylamines
|
|
WO2023147423A1
(en)
|
2022-01-28 |
2023-08-03 |
Miralogx Llc |
Anxiolytic compounds, pharmaceutical compositions, and methods of treating anxiety and other disorders
|
|
WO2023141636A1
(en)
|
2022-01-24 |
2023-07-27 |
Terran Biosciences Inc. |
Prodrugs of 2-bromo-lsd (2-bromolysergic acid diethylamide)
|
|
WO2023147424A1
(en)
|
2022-01-27 |
2023-08-03 |
Terran Biosciences, Inc. |
Salts and solid forms of n-ethyl-2-(5-fluoro-1h-indol-3-yl)- n-methylethan-1-amine
|
|
CA3243296A1
(en)
|
2022-02-01 |
2023-08-10 |
Caamtech, Inc. |
PSYCHEDELIC COMPOUNDS AND THEIR THERAPEUTIC USES
|
|
EP4479365A4
(en)
|
2022-02-16 |
2026-03-11 |
Terran Biosciences Inc |
IDAZOXAN DEUTERE AND ITS METHODS OF USE
|
|
JP2025515146A
(ja)
|
2022-05-06 |
2025-05-13 |
ブライト マインズ バイオサイエンスィズ インコーポレイテッド |
アゼピノインドール及びその調製方法
|
|
US20240000795A1
(en)
|
2022-06-30 |
2024-01-04 |
Terran Biosciences Inc. |
Methods and compositions relating to controlling psychedelic effects with serotonin receptor modulators
|
|
CN117586171A
(zh)
|
2022-08-12 |
2024-02-23 |
长春金赛药业有限责任公司 |
吲哚类衍生物、药物组合物及其在中枢神经领域的应用
|
|
CN117624169A
(zh)
|
2022-08-24 |
2024-03-01 |
上海翊石医药科技有限公司 |
一类5-ht2a受体激动剂及其制备方法和应用
|
|
WO2024059495A1
(en)
|
2022-09-12 |
2024-03-21 |
The Regents Of The University Of California |
Methods of preparing ergoline analogs
|